AEDIFICA (AED.BR) Stock Fundamental Analysis
EBR:AED - Euronext Brussels - BE0003851681 - REIT - Currency: EUR
Taking everything into account, AED scores 4 out of 10 in our fundamental rating. AED was compared to 42 industry peers in the Diversified REITs industry. There are concerns on the financial health of AED while its profitability can be described as average. AED is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year AED was profitable.
In the past year AED had a positive cash flow from operations.
AED had positive earnings in each of the past 5 years.
AED had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
AED has a better Return On Assets (3.17%) than 69.05% of its industry peers.
AED has a Return On Equity of 5.62%. This is in the better half of the industry: AED outperforms 61.90% of its industry peers.
AED has a Return On Invested Capital (3.28%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for AED is in line with the industry average of 3.74%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 5.62% | ||
| ROIC | 3.28% |
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
1.3 Margins
AED has a Profit Margin of 60.60%. This is in the better half of the industry: AED outperforms 71.43% of its industry peers.
AED's Profit Margin has declined in the last couple of years.
The Operating Margin of AED (76.93%) is better than 69.05% of its industry peers.
AED's Operating Margin has been stable in the last couple of years.
AED has a Gross Margin of 97.67%. This is amongst the best in the industry. AED outperforms 95.24% of its industry peers.
AED's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 76.93% | ||
| PM (TTM) | 60.6% | ||
| GM | 97.67% |
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AED is destroying value.
AED has about the same amout of shares outstanding than it did 1 year ago.
AED has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AED has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.86, we must say that AED is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.86, AED perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
A Debt/Equity ratio of 0.57 indicates that AED is somewhat dependend on debt financing.
The Debt to Equity ratio of AED (0.57) is better than 73.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.86 |
ROIC/WACC0.51
WACC6.38%
2.3 Liquidity
A Current Ratio of 0.32 indicates that AED may have some problems paying its short term obligations.
AED has a worse Current ratio (0.32) than 71.43% of its industry peers.
A Quick Ratio of 0.32 indicates that AED may have some problems paying its short term obligations.
With a Quick ratio value of 0.32, AED is not doing good in the industry: 69.05% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.32 | ||
| Quick Ratio | 0.32 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 465.39% over the past year.
Measured over the past years, AED shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.20% on average per year.
Looking at the last year, AED shows a small growth in Revenue. The Revenue has grown by 7.97% in the last year.
Measured over the past years, AED shows a very strong growth in Revenue. The Revenue has been growing by 23.35% on average per year.
EPS 1Y (TTM)465.39%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%152.09%
Revenue 1Y (TTM)7.97%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%7.99%
3.2 Future
The Earnings Per Share is expected to grow by 2.70% on average over the next years.
Based on estimates for the next years, AED will show a small growth in Revenue. The Revenue will grow by 5.06% on average per year.
EPS Next Y2.38%
EPS Next 2Y3.16%
EPS Next 3Y2.7%
EPS Next 5YN/A
Revenue Next Year5.73%
Revenue Next 2Y5.48%
Revenue Next 3Y5.06%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
AED is valuated correctly with a Price/Earnings ratio of 15.72.
The rest of the industry has a similar Price/Earnings ratio as AED.
When comparing the Price/Earnings ratio of AED to the average of the S&P500 Index (28.79), we can say AED is valued slightly cheaper.
The Price/Forward Earnings ratio is 13.44, which indicates a correct valuation of AED.
61.90% of the companies in the same industry are cheaper than AED, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.38. AED is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.72 | ||
| Fwd PE | 13.44 |
4.2 Price Multiples
AED's Enterprise Value to EBITDA ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 21.74 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
AED has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)6.62
PEG (5Y)N/A
EPS Next 2Y3.16%
EPS Next 3Y2.7%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.05%, AED is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 7.73, AED is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.47, AED pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.05% |
5.2 History
The dividend of AED is nicely growing with an annual growth rate of 22.82%!
Dividend Growth(5Y)22.82%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
81.46% of the earnings are spent on dividend by AED. This is not a sustainable payout ratio.
The dividend of AED is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP81.46%
EPS Next 2Y3.16%
EPS Next 3Y2.7%
EBR:AED (4/25/2025, 7:00:00 PM)
67.75
+0.35 (+0.52%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners42.88%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap3.22B
Analysts79.05
Price Target72.45 (6.94%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.05% |
Yearly Dividend3.51
Dividend Growth(5Y)22.82%
DP81.46%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.05%
PT rev (3m)1.55%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.2%
EPS NY rev (3m)1.63%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-0.02%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.72 | ||
| Fwd PE | 13.44 | ||
| P/S | 9.53 | ||
| P/FCF | N/A | ||
| P/OCF | 12.96 | ||
| P/B | 0.88 | ||
| P/tB | 0.91 | ||
| EV/EBITDA | 21.74 |
EPS(TTM)4.31
EY6.36%
EPS(NY)5.04
Fwd EY7.44%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)5.23
OCFY7.71%
SpS7.11
BVpS76.61
TBVpS74.75
PEG (NY)6.62
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 5.62% | ||
| ROCE | 4.38% | ||
| ROIC | 3.28% | ||
| ROICexc | 3.29% | ||
| ROICexgc | 3.34% | ||
| OM | 76.93% | ||
| PM (TTM) | 60.6% | ||
| GM | 97.67% | ||
| FCFM | N/A |
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
ROICexc(3y)3.34%
ROICexc(5y)3.28%
ROICexgc(3y)3.4%
ROICexgc(5y)3.38%
ROCE(3y)4.43%
ROCE(5y)4.34%
ROICexcg growth 3Y6.29%
ROICexcg growth 5Y0.95%
ROICexc growth 3Y7%
ROICexc growth 5Y0.65%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
F-Score8
Asset Turnover0.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.85 | ||
| Cap/Depr | 8867.91% | ||
| Cap/Sales | 76.19% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 94.51% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.32 | ||
| Quick Ratio | 0.32 | ||
| Altman-Z | 0.86 |
F-Score8
WACC6.38%
ROIC/WACC0.51
Cap/Depr(3y)11089%
Cap/Depr(5y)16628.2%
Cap/Sales(3y)126.51%
Cap/Sales(5y)150.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)465.39%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%152.09%
EPS Next Y2.38%
EPS Next 2Y3.16%
EPS Next 3Y2.7%
EPS Next 5YN/A
Revenue 1Y (TTM)7.97%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%7.99%
Revenue Next Year5.73%
Revenue Next 2Y5.48%
Revenue Next 3Y5.06%
Revenue Next 5YN/A
EBIT growth 1Y8.46%
EBIT growth 3Y15.21%
EBIT growth 5Y24.47%
EBIT Next Year10.71%
EBIT Next 3Y6.49%
EBIT Next 5YN/A
FCF growth 1Y88.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.26%
OCF growth 3Y7.82%
OCF growth 5Y22.86%